Olaratumab
Olaratumab Basic information
- Product Name:
- Olaratumab
- Synonyms:
-
- Olaratumab
- Research Grade Olaratumab(DHD16101)
- IMC 3G3
- IMC3G3
- IMC-3G3
- Lartruvo
- LY 3012207
- LY3012207
- CAS:
- 1024603-93-7
- MW:
- 0
- Mol File:
- Mol File
More
Less
Olaratumab Usage And Synthesis
Clinical Use
Monoclonal antibody:
Treatment of advanced soft tissue sarcoma in
combination with doxorubicin
Drug interactions
Potentially hazardous interactions with other drugs
Live vaccines: avoid with olaratumab in combination
with doxorubicin.
Metabolism
Mainly degraded non-specifically by proteolytic enzymes.
OlaratumabSupplier
BOC Sciences
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 17754423994 17754423994
- 2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 15926423062
- 422450190@qq.com
AntibodySystem
- Tel
- 027-65279366 18162686757
- biolab-reagents@atagenix.com